BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Diagnosis
5 results:

  • 1. Bioinformatics Analysis Screened and Identified Key Genes as Potential Biomarkers for Progression of lung cancer.
    Chen Y; Wang XK; Wang Y; Zong JW; Wang SY; Wan XY
    J Coll Physicians Surg Pak; 2022 Jun; 32(6):712-721. PubMed ID: 35686401
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of miR-486-5p and its significance in lung squamous cell carcinoma.
    Yang S; Sui J; Liu T; Wu W; Xu S; Yin L; Pu Y; Zhang X; Zhang Y; Shen B; Liang G
    J Cell Biochem; 2019 Aug; 120(8):13912-13923. PubMed ID: 30963622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer.
    Gao ZJ; Yuan WD; Yuan JQ; Yuan K; Wang Y
    Pathol Res Pract; 2018 May; 214(5):700-705. PubMed ID: 29567332
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
    Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
    PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.